MedTrace Logo

Clinical Investigation of AcrySof® IQ ReSTOR® +2.5 D Multifocal Intraocular Lens (IOL) Model SN6AD2 [SV25T0]

NCT01510717 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 409

Last updated 2015-05-27

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the safety and efficacy of an investigational multifocal intraocular lens (IOL) to an FDA-approved monofocal IOL.

Conditions

  • Cataracts

Interventions

DEVICE

AcrySof® IQ ReSTOR® +2.5 D Multifocal IOL Model SN6AD2 [SV25T0]

Multifocal IOL with extended secondary focal point implanted for long-term use over the lifetime of the cataract patient

DEVICE

AcrySof® IQ Monofocal IOL Model SN60WF

Monofocal IOL implanted for long-term use over the lifetime of the cataract patient

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Magda Michna, PhD · Alcon Research

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-12-31
Completion
2012-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01510717 on ClinicalTrials.gov